News | August 02, 2011

Accuray Symposium at Joint AAPM/COMP Meeting Highlights Quality Assurance in Radiation Oncology

Aug. 2, 2011 — Accuray Inc. announced it will showcase the CyberKnife robotic radiosurgery system and the TomoTherapy radiation therapy treatment system at the 2011 Joint American Association of Physicists in Medicine (AAPM)/Canadian Organization of Medical Physicists (COMP) meeting. The company will also host a joint symposium examining best practices for quality assurance (QA) in radiation oncology. The 2011 Joint AAPM/COMP meeting takes place July 31-Aug. 4, 2011 in Vancouver, British Columbia.

Accuray will host a symposium at the Fairmont Pacific Rim Star Sapphire Ballroom entitled "Best Quality Assurance Programs for Today's Radiation Oncology Platforms." Sonja Dieterich, Ph.D., DABR, chief of clinical physics at Stanford University School of Medicine, will discuss the protocols and recommendations of task group TG-135, which has been dedicated to setting QA standards in the field of robotic radiosurgery.

Sasa Mutic, Ph.D., DABR, chief of clinical medical physics and associate professor of radiation oncology at Washington University School of Medicine, will discuss how systems' engineering principles can be applied to radiotherapy QA and quality compliance (QC). Attendees interested in participating in the symposium may register online.

In addition to the symposium, several studies from leading hospitals and academic centers will showcase both the CyberKnife system and the TomoTherapy system. Highlights from the more than 60 CyberKnife and TomoTherapy-related topics from the conference include:

-"Experience with Helical TomoTherapy Commissioning and Quality Assurance of Twin Peaks Linac vs. Earlier Models"—Conducted at the Pomona Valley Hospital Medical Center in Pomona, Calif., this study evaluated the new Twin Peak linear accelerator in the TomoTherapy system. Researchers found beam performance to be consistent with that of a treatment unit employing an earlier model of linear accelerator. Additionally, this study found that throughout nine months of clinical use, no changes in beam characteristics were observed. The study concludes that the new linear accelerator represents an improvement in technology in terms of beam stability and in the lifetime of this system component.

-"CyberKnife Treatment of Endometrial Cervical Cancer"—Conducted at the Fox Chase Cancer Center in Philadelphia, Pa., this research investigated the potential use of the CyberKnife system for the treatment of cervical cancer as an alternative to brachytherapy, an invasive and often painful treatment option. As the authors state, this study demonstrated that CyberKnife treatment can be a viable alternative to endometrial brachytherapy treatments, which may greatly improve the patient care.

-"CyberKnife Treatment for Early Stage Oral Tongue Cancer – Feasibility Study"—Conducted at the Fox Chase Cancer Center in Philadelphia, Pa., this study evaluated use of the CyberKnife system to treat oral tongue cancer. The treatment planning study found that the system could deliver conformal dose in 5 fractions that kept radiation dose to the mandible low, providing patients with a more comfortable and less invasive alternative to conventional brachytherapy. Authors estimate treatment time will be 18 min./fraction.

For more information: www.accuray.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Overlay Init